Below are the most recent publications written about "ST Elevation Myocardial Infarction" by people in Profiles.
-
Elbadawi A, Hamed M, Gad M, Elseidy SA, Barghout M, Jneid H, Mamas MA, Alfonso F, Elgendy IY. Immediate Versus Staged Complete Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis of Randomized Trials. J Am Heart Assoc. 2024 Nov 05; 13(21):e035535.
-
Dafaalla M, Costa F, Kontopantelis E, Araya M, Kinnaird T, Micari A, Jia H, Mintz GS, Mamas MA. Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score. Eur Heart J. 2024 Sep 07; 45(34):3138-3148.
-
Dziewierz A, Rakowski T, Mamas MA, Tkaczyk F, Sowa L, Malinowski KP, Olszanecka A, Siudak Z. Impact of historical partitions of Poland on reperfusion delay in patients with ST-segment elevation myocardial infarction referred for primary percutaneous coronary intervention (from the ORPKI Registry). Pol Arch Intern Med. 2024 08 08; 134(7-8).
-
Matetic A, Kyriacou T, Mamas MA. Machine-learning clustering analysis identifies novel phenogroups in patients with ST-elevation acute myocardial infarction. Int J Cardiol. 2024 Sep 15; 411:132272.
-
Moledina SM, Matetic A, Weight N, Rashid M, Sun L, Fischman DL, Van Spall HGC, Mamas MA. Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis. Eur Heart J Qual Care Clin Outcomes. 2024 May 22; 10(3):216-227.
-
Mohamed MO, Kontopantelis E, Alasnag M, Abid L, Banerjee A, Sharp ASP, Bourantas C, Sirker A, Curzen N, Mamas MA. Impact of Society Guidelines on Trends in Use of Newer P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 May 07; 13(9):e034414.
-
Mamas MA, Martin GP, Grygier M, Wadhera RK, Mallen C, Curzen N, Wijeysundera HC, Banerjee A, Kontopantelis E, Rashid M, Sielski J, Siudak Z. Indirect impact of the war in Ukraine on primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in Poland. Pol Arch Intern Med. 2024 06 27; 134(6).
-
Dawson LP, Rashid M, Dinh DT, Brennan A, Bloom JE, Biswas S, Lefkovits J, Shaw JA, Chan W, Clark DJ, Oqueli E, Hiew C, Freeman M, Taylor AJ, Reid CM, Ajani AE, Kaye DM, Mamas MA, Stub D. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score. Circ Cardiovasc Interv. 2024 Apr; 17(4):e013738.
-
Lunardi M, Mamas MA, Mauri J, Molina CM, Rodriguez-Leor O, Eggington S, Pietzsch JB, Papo NL, Walleser-Autiero S, Baumbach A, Maisano F, Ribichini FL, Mylotte D, Barbato E, Piek JJ, Wijns W, Naber CK. Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries. Eur Heart J Qual Care Clin Outcomes. 2024 Jan 12; 10(1):25-35.
-
Dafaalla M, Abdel-Qadir H, Gale CP, Sun L, L?pez-Fern?ndez T, Miller RJH, Wojakowski W, Nolan J, Rashid M, Mamas MA. Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study. Eur Heart J Qual Care Clin Outcomes. 2023 12 22; 9(8):806-817.